New Dexcom G6 Users

Learn More >

Self-funded Existing Dexcom G6 Users

Learn More >

New Dexcom G6 Users Users with Type 1 Diabetes

Category A - For people with type 1 diabetes aged 21 years or older

As of 1st August 2022, all individuals whether new Dexcom G6 users or self-funded existing Dexcom G6 users, will now follow the same process as outlined below:

  1. Review the eligibility criteria available at ndss.com.au/about-the-ndss/cgm-initiative/ and speak to your healthcare professional (HCP) to see which product is right for you
  2. Complete the relevant Access Form found at ndss.com.au/about-the-ndss/cgm-initiative/. This needs to be prepared and signed by your HCP 
  3. Diabetes Australia will contact you to confirm eligibility for access to subsidised CGM products
  4. The initial Dexcom kit will be sent to your HCP for the Dexcom start 
  5. Following on from here, you can order and collect supplies from your local NDSS Checkpoint pharmacy 

For more information on this process, please contact NDSS directly on 1800 637 700.

Note: prior to receiving subsidised Dexcom G6 via this subsidy expansion, we ask that you check your mobile device is compatible as a display device at dexcom.com/en-AU/compatibility

 

Self-funded Dexcom G6 users with Type 1 Diabetes 

Category B - for self-funded CGM users with type 1 diabetes

Note: As of 31st July 2022, the streamlined process for self-funded existing Dexcom G6 users has now closed.

As of 1st August 2022, all individuals whether self-funded existing Dexcom G6 users or new Dexcom G6 users, will now follow the same process as outlined below:

  1. Review the eligibility criteria available at ndss.com.au/about-the-ndss/cgm-initiative/ and speak to your healthcare professional (HCP) to see which product is right for you
  2. Complete the relevant Access Form found at ndss.com.au/about-the-ndss/cgm-initiative/. This needs to be prepared and signed by your HCP 
  3. Diabetes Australia will contact you to confirm eligibility for access to subsidised CGM products
  4. The initial Dexcom kit will be sent to your HCP for the Dexcom start 
  5. Following on from here, you can order and collect supplies from your local NDSS Checkpoint pharmacy 

For more information on this process, please contact NDSS directly on 1800 637 700.

Note: prior to receiving subsidised Dexcom G6 via this subsidy expansion, we ask that you check your mobile device is compatible as a display device at dexcom.com/en-AU/compatibility

 

.

How can I access the Dexcom G6 Subsidy?

The streamlined process for existing self-funded users has now closed, as of 31st of July 2022.

All individuals, whether new Dexcom G6 users or existing Dexcom G6 users will now need to following the process outlined below.

Subsidy Application Process (after 31 July 22)

Looking to switch over to Dexcom?

Already on the CGM Subsidy Initiative but wanting to switch to Dexcom CGM?

NDSS registrants are able to switch from another subsidised CGM product to Dexcom G6 anytime!

Speak to your healthcare professional today to see if Dexcom is right for you. Your healthcare professional will be able to submit a switch form on your behalf to the NDSS.

Step 1: You can download the switching (Update or Cease Access) form here

Step 2: Take it to your next appointment with your healthcare professional.

ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on amsldiabetes.com.au/resources before purchasing. Consult your healthcare professional to see which product is right for you.

Last updated: 10th August 2022

† Smart device and Receiver not included with Dexcom G6 CGM system. For a list of compatible devices, please visit dexcom.com/compatibility
‡ Do not make treatment decisions based upon Share and Follow readings. Always confirm with your compatible smart device or Receiver.
§ Compared to Dexcom G5 Mobile CGM
¶ Do not make treatment decisions based upon Share or Follow readings. Always confirm with your compatible smart device or Receiver. Internet connectivity required to access Dexcom Follow.
Dexcom, Dexcom G6, Dexcom Share and Dexcom CLARITY are registered trademarks of Dexcom, Inc. in the United States and/or other countries. ARTG 330535.

References: 1. Wadwa RP, Laffel LM, Shah VN, Garg SK. Accuracy of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes. 2.Beck RW, et al. DIAMOND - JAMA. 2017. 3. Soupal J et al. COMISAIR, Diabetes Technol Ther. 2016. 4. Heinemann L,et al. HypoDE, Lancet. 2018. 5. Reddy M et al. iHart CGM Diabet Med. 2018. 6. Lind M, et al. GOLD JAMA. 2017.

Back to top